结核病中的宿主微生物群:疾病,治疗和免疫视角
Archana Pant1, Bhabatosh Das2, Gopalakrishnan Aneeshkumar Arimbasseri1
1Molecular Genetics Lab, National Institute of Immunology, New Delhi, India.
Frontiers in microbiology
|October 9, 2023
概括
结核病治疗会破坏肠道微生物群,影响营养吸收和免疫功能. 恢复肠道细菌可能会改善治疗结果,并对抗Mycobacterium结核病的抗生素耐药性.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 结核病 (TB) 是一种由Mycobacterium tuberculosis (M. tb) 引起的空气传播疾病.
- 结核病治疗涉及长时间使用抗生素,导致副作用和抗生素耐药性.
- 抗结核药物破坏肠道微生物群,影响宿主免疫力和新陈代谢.
研究的目的:
- 审查结核病和治疗期间肠道微生物群的结构和功能变化.
- 探索肠道微生物群,微量营养素和结核病中的免疫动态之间的联系.
- 总结抗菌素耐药性和基于微生物组的结核病治疗方法.
主要方法:
- 结核病,肠道微生物群和治疗效果的文献综述.
- 微生物社区结构和功能的分析.
- 检查宿主微生物相互作用和免疫反应.
主要成果:
- 结核病及其治疗显著减少了肠道微生物多样性和关键细菌种群.
- 改变的肠道微生物群会影响微量营养素配置和免疫细胞动态.
- 肠道功能失调可能导致治疗结果不佳和M. tb抗生素耐药性.
结论:
- 了解肠道微生物群的变化对于结核病管理至关重要.
- 基于微生物组的治疗方法为结核病治疗和预防提供了潜力.
- 准肠道微生物群可以提高结核病治疗效率和抗击耐药性.
相关概念视频
Pulmonary Tuberculosis V
186
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
186
Pulmonary Tuberculosis II
246
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
246
Pulmonary Tuberculosis I
249
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
249
Pulmonary Tuberculosis IV
148
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
148
Pulmonary Tuberculosis III
348
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
348
Microorganisms in Medicine and Therapeutics
37
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
37


